Brief: China Shineway Pharmaceutical Group Appoints Xu Sheng As Executive Director And CEO
30/11/2018 09:46
Nov 30 (Reuters) - China Shineway Pharmaceutical Group Ltd
2877.HK :
* XU SHENG APPOINTED AS EXECUTIVE DIRECTOR AND CHIEF
EXECUTIVE
OFFICER
* LI ZHENJIANG WILL CEASE TO SERVE AS PRESIDENT OF COMPANY
Source text for Eikon: ID:nHKS9cKrpf
Further company coverage: 2877.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Shineway Pharmaceutical
See all newsBrief: China Shineway Pharmaceutical Posts Q1 Turnover Of RMB624 MLN
Brief: China Shineway Pharmaceutical Declares 2026 First Interim Dividend RMB43 Cents Per Share
Brief: China Shineway Pharmaceutical Group FY Net Income RMB 840 Million
Brief: China Shineway Pharmaceutical Posts Nine Months Turnover RMB2,887 Mln
Brief: China Shineway Pharmaceutical Group Posts H1 Net Income RMB 626.5 Mln